The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1
Open accessAbstract
Resveratrol is a cancer preventative agent that is found in red wine. Piceatannol is a closely related stilbene that has antileukaemic activity and is also a tyrosine kinase inhibitor. Piceatannol differs from resveratrol by having an additional aromatic hydroxy group. The enzyme CYP1B1 is overexpressed in a wide variety of human tumours and catalyses aromatic hydroxylation reactions. We report here that the cancer preventative agent resveratrol undergoes metabolism by the cytochrome P450 enzyme CYP1B1 to give a metabolite which has been identified as the known antileukaemic agent piceatannol. The metabolite was identified by high performance liquid chromatography analysis using fluorescence detection and the identity of the metabolite was further confirmed by derivatisation followed by gas chromatography-mass spectrometry studies using authentic piceatannol for comparison. This observation provides a novel explanation for the cancer preventative properties of resveratrol. It demonstrates that a natural dietary cancer preventative agent can be converted to a compound with known anticancer activity by an enzyme that is found in human tumours. Importantly this result gives insight into the functional role of CYP1B1 and provides evidence for the concept that CYP1B1 in tumours may be functioning as a growth suppressor enzyme.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W. W., Fong, H. H. S., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., et al. (1997) · Science · doi:10.1126/science.275.5297.218 · Cited by 4,935 · cited 1×
“Resveratrol is a natural product found in red wine, and has been shown to have cancer preventative properties ( Jang et al, 1997; Jang and Pezzuto, 1999).”
BackgroundYang, Y., Li, S., Yang, Q., Shi, Y., Zheng, M., Liu, Y., Chen, F., Song, G., Xu, H., Wan, T., et al. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000358696 · Cited by 3,253
Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1.
Shimada, T., Hayes, C. L., Yamazaki, H., Amin, S., Hecht, S. S., Guengerich, F. P., & Sutter, T. R. (1996) · PubMed · Cited by 895
17 beta-estradiol hydroxylation catalyzed by human cytochrome P450 1B1.
Hayes, C. L., Spink, D. C., Spink, B. C., Cao, J. Q., Walker, N. J., & Sutter, T. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9776 · Cited by 632
Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature.
Dark, G. G., Hill, S. A., Prise, V. E., Tozer, G. M., Pettit, G. R., & Chaplin, D. J. (1997) · PubMed · Cited by 622
Phytoestrogens: epidemiology and a possible role in cancer protection.
Adlercreutz, H. (1995) · Environmental Health Perspectives · doi:10.1289/ehp.95103s7103 · Cited by 553
Tumor-specific expression of cytochrome P450 CYP1B1.
Murray, G. I., Taylor, M. C., McFadyen, M. C. E., McKay, J., Greenlee, W. F., Burke, M. D., & Melvin, W. T. (1997) · PubMed · Cited by 532
Self-citationSutter, T. R., Tang, Y. M., Hayes, C. L., Wo, Y. Y., Jabs, E. W., Li, X., Yin, H., Cody, C. W., & Greenlee, W. F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36803-5 · Cited by 508
Metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-diol by human cytochrome P450 1B1
Kim, J. (1998) · Carcinogenesis · doi:10.1093/carcin/19.10.1847 · Cited by 286
Bioflavonoids: selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1
Doostdar, H., Burke, M. D., & Mayer, R. T. (2000) · Toxicology · doi:10.1016/s0300-483x(99)00215-2 · Cited by 284
Self-citationWolter, F., Akoglu, B., Clausnitzer, A., & Stein, J. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.8.2197 · Cited by 236
Cancer chemopreventive activity of resveratrol.
Jang, M., & Pezzuto, J. M. (1999) · PubMed · Cited by 225
Geahlen, R. L., & McLaughlin, J. L. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)91060-7 · Cited by 202
Spink, D. C., Hayes, C. L., Young, N. R., Christou, M., Sutter, T. R., Jefcoate, C. R., & Gierthy, J. F. (1994) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)90037-x · Cited by 195
Fleming, I., Fisslthaler, B., & Busse, R. (1995) · Circulation Research · doi:10.1161/01.res.76.4.522 · Cited by 176
Thakkar, K., Geahlen, R. L., & Cushman, M. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00072a015 · Cited by 165
Ultraviolet-B Exposure of Human Skin Induces Cytochromes P450 1A1 and 1B1
Katiyar, S. K., Mukhtar, H., & Matsui, M. S. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00876.x · Cited by 159
Li, D. N., Seidel, A., Pritchard, M. P., Wolf, C. R., & Friedberg, T. (2000) · Pharmacogenetics · doi:10.1097/00008571-200006000-00008 · Cited by 152
Peters, J. D., Furlong, M. T., Asai, D. J., Harrison, M. L., & Geahlen, R. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.9.4755 · Cited by 145
Distinct Mechanisms of STAT Phosphorylation via the Interferon-α/β Receptor
Su, L., & David, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.17.12661 · Cited by 133
McFadyen, M. C. E., Breeman, S., Payne, S., Stirk, C. M., Miller, I. D., Melvin, W. T., & Murray, G. I. (1999) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549904701111 · Cited by 120
Lu, J., Ho, C., Ghai, G. R., & Chen, K. Y. (2001) · Carcinogenesis · doi:10.1093/carcin/22.2.321 · Cited by 98
Adhami, V. M., Afaq, F., & Ahmad, N. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5819 · Cited by 83
Cited by
The therapeutic potential of resveratrol: a review of clinical trials
Berman, A. Y., Motechin, R. A., Wiesenfeld, M. Y., & Holz, M. K. (2017) · npj Precision Oncology · doi:10.1038/s41698-017-0038-6 · Cited by 888
Resveratrol as an anti-inflammatory and anti-aging agent: Mechanisms and clinical implications
Alarcón de la Lastra, C., & Villegas, I. (2005) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200500022 · Cited by 703
Shimada, T. (2006) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.21.257 · Cited by 606
Resveratrol bioavailability and toxicity in humans
Cottart, C., Nivet‐Antoine, V., Laguillier‐Morizot, C., & Beaudeux, J. (2010) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200900437 · Cited by 592
Resveratrol, Pterostilbene, and Piceatannol in Vaccinium Berries
Rimando, A. M., Kalt, W., Magee, J. B., Dewey, J., & Ballington, J. R. (2004) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf040095e · Cited by 582
Metadata
- Authors
- Potter, G. A., Patterson, L. H., Wanogho, E., Perry, P. J., Butler, P. C., Ijaz, T., Ruparelia, K. C., Lamb, J. H., Farmer, P. B., Stanley, L. A., & Burke, M. D.
- Venue
- British Journal of Cancer
- Published
- 2002-02-26
- Volume
- 86
- Issue
- 5
- Pages
- 774-778
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2126655188
- Cited by
- 380
- References
- 23
- FWCI
- 10.61
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.